Adalimumab for Endoscopic and Histopathological Mucosal Healing in Paediatric Patients With Moderate to Severe Crohn’s Disease

Przeglad Gastroenterologiczny - Poland
doi 10.5114/pg.2016.64746
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience

Przeglad Gastroenterologiczny
Gastroenterology
2012English

Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease

Journal of Clinical Gastroenterology
Gastroenterology
2013English

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Gastroenterology
HepatologyGastroenterology
2019English

Pgi21 - Cost-Effectiveness Analysis of Ustekinumab Versus Adalimumab, Infliximab and Vedolizumab for the Treatment of Patients With Moderately to Severe Active Crohn’s Disease for Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

Safety Profile of Biologic Therapy in Polish Paediatric Patients With Crohn’s Disease

Przeglad Gastroenterologiczny
Gastroenterology
2015English

Risk Factors for Cardiovascular Disease in Patients With COPD: Mild-To-Moderate COPD Versus Severe-To-Very Severe COPD

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2016English

P090 Restoration of Health in Patients With Inflammatory Bowel Disease and Mucosal Healing

Journal of Crohn's and Colitis
MedicineGastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy